I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 21% ± 6% | |
| epithelial cell | 5 studies | 26% ± 10% | |
| natural killer cell | 4 studies | 19% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 0% | |
| non-classical monocyte | 3 studies | 23% ± 5% | |
| fibroblast | 3 studies | 21% ± 5% | |
| abnormal cell | 3 studies | 20% ± 3% | |
| GABAergic neuron | 3 studies | 29% ± 6% | |
| astrocyte | 3 studies | 16% ± 1% | |
| glutamatergic neuron | 3 studies | 39% ± 10% | |
| dendritic cell | 3 studies | 32% ± 8% | |
| basal cell | 3 studies | 24% ± 6% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 3% |
